Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2021

View Archived Issues

AstraZeneca patents SLC12A5 activators

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Evotec presents ISR pathway modulators

MCT4 is a prognostic marker in anaplastic thyroid cancer

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

SG-3-00802 shows encouraging preclinical activity in combination with anti-PD-1 therapy

HC-070 attenuates stress-related excessive sensitivity to aversion and apathy for reward in mice

Stealth's SBT-272 shows promise in murine model of ALS

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

NK-92 with truncated PD-1 shows enhanced therapeutic effects

Dapiglutide attenuates intestinal insufficiency in vivo

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Rare APOE variant gives insight into Alzheimer's pathogenesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...